Denis Chem Lab Limited
DENISCHEM.BO
Get informed when a big investor buys or sells
+ FollowMarket Cap$909.62M
Close$
$64.32
1.2% upside
Current Fair Value
1.2% upsideUndervalued by 1.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $909.62 Million |
|---|---|
| Enterprise Value | $946.87 Million |
| Dividend Yield | $2.50 (3.81%) |
| Earnings per Share | $6.06 |
| Beta | 1.52 |
| Outstanding Shares | 13,876,668 |
Return
| Return on Equity | 8.71% |
|---|---|
| Return on Assets | 6.39% |
| Return on Invested Capital | 11.91% |
Valuation & Multiples
| P/E Ratio | 11.4 |
|---|---|
| PEG | -65.65 |
| Price to Sales | 0.49 |
| Price to Book Ratio | 0.98 |
| Enterprise Value to Revenue | 0.52 |
| Enterprise Value to EBIT | 8.53 |
| Enterprise Value to Net Income | 11 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Denis Chem Lab Limited
183 employees
CEO: Nirmal Himanshu Patel Denis Chem Lab Limited specializes in the production and distribution of bottled transfusion solutions. Its product offerings include a variety of injectable pharmaceuticals, such as antibiotics, diuretics, parenteral amino acids, and an...